Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Matzke

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1996
Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agentsG R Matzke
Clinical Pharmacy|July 1, 1984
Does plasma exchange alter drug therapy?G R Matzke
The Annals of Pharmacotherapy|April 1, 1994
Pharmacotherapeutic consequences of recent advances in hemodialysis therapyG R Matzke
Hospital Pharmacy|May 9, 1988
Clinical trials: a basic bibliography (#44)G R Matzke
The Annals of Pharmacotherapy|February 1, 1997
Clinical consequences of nonnarcotic analgesic useG R Matzke
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 10, 1999
Intravenous iron supplementation in end-stage renal disease patientsG R Matzke
Clinical Pharmacy|January 1, 1982
Treating severe metabolic alkalosisW J Martin, G R Matzke
Antimicrobial Agents and Chemotherapy|March 1, 1983
Cefsulodin pharmacokinetics in patients with various degrees of renal functionG R Matzke, W F Keane
American Journal of Hospital Pharmacy|October 1, 1981
Nephropathy as a hazard of analgesic abuseJ V Anandan, G R Matzke
American Journal of Hospital Pharmacy|July 1, 1979
Effect of quinidine on serum digoxin concentrationsW S Burkle, G R Matzke
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1996
Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agentsG R Matzke
Clinical Pharmacy|July 1, 1984
Does plasma exchange alter drug therapy?G R Matzke
The Annals of Pharmacotherapy|April 1, 1994
Pharmacotherapeutic consequences of recent advances in hemodialysis therapyG R Matzke
Hospital Pharmacy|May 9, 1988
Clinical trials: a basic bibliography (#44)G R Matzke
The Annals of Pharmacotherapy|February 1, 1997
Clinical consequences of nonnarcotic analgesic useG R Matzke
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 10, 1999
Intravenous iron supplementation in end-stage renal disease patientsG R Matzke
Clinical Pharmacy|January 1, 1982
Treating severe metabolic alkalosisW J Martin, G R Matzke
Antimicrobial Agents and Chemotherapy|March 1, 1983
Cefsulodin pharmacokinetics in patients with various degrees of renal functionG R Matzke, W F Keane
American Journal of Hospital Pharmacy|October 1, 1981
Nephropathy as a hazard of analgesic abuseJ V Anandan, G R Matzke
American Journal of Hospital Pharmacy|July 1, 1979
Effect of quinidine on serum digoxin concentrationsW S Burkle, G R Matzke
Pageof 13